| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |